110 related articles for article (PubMed ID: 3211364)
1. Effects of exposure in utero to methadone and buprenorphine on enkephalin levels in the developing rat brain.
Tiong GK; Olley JE
Neurosci Lett; 1988 Oct; 93(1):101-6. PubMed ID: 3211364
[TBL] [Abstract][Full Text] [Related]
2. Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny.
Robinson SE
Neurotoxicol Teratol; 2002; 24(2):137-42. PubMed ID: 11943501
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of tolerance development to morphine in rats prenatally exposed to morphine, methadone, and buprenorphine.
Chiang YC; Hung TW; Lee CW; Yan JY; Ho IK
J Biomed Sci; 2010 Jun; 17(1):46. PubMed ID: 20529288
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
5. Chronic in utero buprenorphine exposure causes prolonged respiratory effects in the guinea pig neonate.
Wallisch M; Subban CV; Nettleton RT; Olsen GD
Neurotoxicol Teratol; 2010; 32(3):398-405. PubMed ID: 20043989
[TBL] [Abstract][Full Text] [Related]
6. High Accumulation of Methadone Compared with Buprenorphine in Fetal Rat Brain after Maternal Exposure.
Kongstorp M; Bogen IL; Stiris T; Andersen JM
J Pharmacol Exp Ther; 2019 Oct; 371(1):130-137. PubMed ID: 31358559
[TBL] [Abstract][Full Text] [Related]
7. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.
Wachman EM; Newby PK; Vreeland J; Byun J; Bonzagni A; Bauchner H; Philipp BL
J Addict Med; 2011 Dec; 5(4):293-9. PubMed ID: 21857233
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats.
Kongstorp M; Bogen IL; Stiris T; Andersen JM
Drug Alcohol Depend; 2020 Jul; 212():108008. PubMed ID: 32402939
[TBL] [Abstract][Full Text] [Related]
9. [Enkephalin content in sections of the brain of rats undergoing intrauterine exposures to ethanol].
Maĭzelis MIa; Zabludovskiĭ AL
Biull Eksp Biol Med; 1986 Mar; 101(3):311-2. PubMed ID: 3955217
[TBL] [Abstract][Full Text] [Related]
10. Prenatal buprenorphine exposure decreases neurogenesis in rats.
Wu CC; Hung CJ; Shen CH; Chen WY; Chang CY; Pan HC; Liao SL; Chen CJ
Toxicol Lett; 2014 Feb; 225(1):92-101. PubMed ID: 24321744
[TBL] [Abstract][Full Text] [Related]
11. Visual evoked potential latencies of three-year-old children prenatally exposed to buprenorphine or methadone compared with non-opioid exposed children: The results of a longitudinal study.
Whitham JN; Spurrier NJ; Baghurst PA; Weston P; Sawyer MG
Neurotoxicol Teratol; 2015; 52(Pt A):17-24. PubMed ID: 26432025
[TBL] [Abstract][Full Text] [Related]
12. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
13. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials.
Whitham JN; Spurrier NJ; Sawyer MG; Baghurst PA; Taplin JE; White JM; Gordon AL
Neurotoxicol Teratol; 2010; 32(2):280-8. PubMed ID: 19751825
[TBL] [Abstract][Full Text] [Related]
14. Prenatal exposure to methadone or buprenorphine alters µ-opioid receptor binding and downstream signaling in the rat brain.
Kongstorp M; Bogen IL; Steinsland S; Nerem E; Salih TW; Stiris T; Andersen JM
Int J Dev Neurosci; 2020 Aug; 80(5):443-453. PubMed ID: 32484968
[TBL] [Abstract][Full Text] [Related]
15. A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children.
Kelty E; Hulse G
Am J Addict; 2017 Dec; 26(8):845-851. PubMed ID: 29143398
[TBL] [Abstract][Full Text] [Related]
16. Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Morgan MM; Reid RA; Stormann TM; Lautermilch NJ
J Pain; 2014 Nov; 15(11):1102-1109. PubMed ID: 25106089
[TBL] [Abstract][Full Text] [Related]
17. Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat.
Borron SW; Monier C; Risède P; Baud FJ
Hum Exp Toxicol; 2002 Nov; 21(11):599-605. PubMed ID: 12507255
[TBL] [Abstract][Full Text] [Related]
18. Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine.
Bier JB; Finger AS; Bier BA; Johnson TA; Coyle MG
J Perinatol; 2015 Aug; 35(8):656-9. PubMed ID: 25836317
[TBL] [Abstract][Full Text] [Related]
19. Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study.
Jones HE; Suess P; Jasinski DR; Johnson RE
Am J Addict; 2006; 15(1):61-70. PubMed ID: 16449094
[TBL] [Abstract][Full Text] [Related]
20. The effect of prenatal methadone exposure on development and nociception during the early postnatal period of the rat.
Enters EK; Guo HZ; Pandey U; Ko DJ; Robinson SE
Neurotoxicol Teratol; 1991; 13(2):161-6. PubMed ID: 2046635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
